Shares of Tiziana Life Sciences rose after the company said it received positive results from its nasal anti-CD3 monoclonal antibody in traumatic spinal cord injury. The stock was up 5.3% to 84 cents ...
Dr. Saef Izzy, Associate Professor of Neurology at Harvard Medical School, commented, “Treatment with nasal anti-CD3 not only dampened microglial activation but also led to marked improvements in ...
Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its ...
The Nigerian Army has denied the allegation by one of its wounded soldiers, Lance Cpl. Itodo David, that he had been abandoned at the 44 Nigerian Army ...
The work explores the potential of wood waste as an innovative, eco-friendly solution to a growing environmental challenge. This research has the power to not only protect sensitive electronics but al ...